We are hapy to anounce that Biopromic, together with Volkan Ozenci from Karolinska Institute and Simon Atlin from Örebro Univeristy has been awarded a Medtech 4 health grant for development and evaluation of sample treatment platform for infectious disease immunoassaysIn this Project we aim to validate the SpeClean technology as a new standard treatment of samples. This would allow many more infectious disease diagnostics to be performed at primary health care centers or at the patient’s bedside.
SpeClean is our new sample preparation technology directed at improving the performance of currently available immunoassays for infectious diseases. The sample treatment aims to remove inhibitory substances from biological samples like urine, saliva or blood, which results in a significant improvement in the sensitivity of the test and reduces unspecific background. In turn, this allows for simpler and more robust tests to be utilized in place of traditional assays.
Project is a cooperation of Biopromic AB, Karolinska Institute and Örebro University Hospital and will last for 18 months starting February 2019, with Vinnova support of over 1,4mln SEK.